Recently, both patients and a mouse model with a homozygous mutation in TFRC exhibited combined immunodeficiency, which is characterized by impaired proliferation of T and B cells and defective class switching, which is essential for antibody production [42, 43]. This evidence concerns the gene TFRC and immune system disorder.